NAKAMOTO INC: TOTAL VALUE OF THIS ASSESSMENT REACHES $107,295,354
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 17 2026
0mins
Should l Buy NAKA?
Source: moomoo
- Combined Value: The total combined value of the consideration is $107,295,354.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NAKA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NAKA
Wall Street analysts forecast NAKA stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.252
Low
1.00
Averages
1.25
High
1.50
Current: 0.252
Low
1.00
Averages
1.25
High
1.50
About NAKA
Nakamoto Inc. is a Bitcoin company that owns and operates a global portfolio of Bitcoin-native enterprises spanning media and information, asset management, and advisory services. It plans to grow its Bitcoin holdings through disciplined accumulation and to leverage its treasury to acquire and develop an ecosystem of Bitcoin companies across finance, media, advisory and more. It provides commercial and financial infrastructure for the capital markets. It owns BTC Inc, which provides Bitcoin-related media and events. It also owns UTXO Management GP, LLC (UTXO) which is an investment firm focused on private and public Bitcoin companies. UTXO is focused on Bitcoin related securities, and derivatives.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nakamoto Completes Acquisition of BTC Inc and UTXO
- Transaction Completion: Nakamoto Inc. successfully completed the acquisition of BTC Inc and UTXO, with a total transaction value of $81.6 million paid in Nakamoto common stock, marking a significant consolidation and expansion in the Bitcoin sector.
- Financial Performance: According to preliminary unaudited results, BTC Inc and UTXO generated approximately $80.5 million in revenue, $34.2 million in EBITDA, and $40.1 million in net income for the 12-month period ending September 30, 2025, demonstrating strong profitability and market positioning.
- Market Leadership: BTC Inc, as the world's largest Bitcoin media company, operates 27 media brands reaching around 6 million people, with its Bitcoin Conference attracting 67,000 attendees, further solidifying its leadership in the Bitcoin ecosystem.
- Investment and Advisory Services: UTXO serves as an adviser to 210k Capital, focusing on Bitcoin-related investments, and is expected to leverage its extensive experience in the Bitcoin ecosystem to enhance Nakamoto's capital allocation across public and private markets, strengthening the company's investment portfolio.
See More
Nakamoto Acquires BTC Inc and UTXO to Expand Bitcoin Services
- Strategic Acquisition: Nakamoto Inc. announced the acquisition of BTC Inc, a leading Bitcoin media company, and UTXO, an investment firm focused on Bitcoin, with the transaction expected to close in Q1 2026, marking a significant step in the company's Bitcoin ecosystem strategy.
- Equity Financing: The transaction will be financed entirely with Nakamoto common stock at a price of $1.12 per share, with BTC Inc and UTXO securityholders receiving 363,589,816 shares, representing a total value of $107,295,354, reflecting the company's confidence in future growth.
- Market Leadership: BTC Inc is the largest Bitcoin media company globally, with a portfolio of 27 media brands reaching approximately 6 million people, and its leadership in Bitcoin events will provide Nakamoto with substantial market influence and brand value.
- Growth Potential: By integrating BTC Inc and UTXO, Nakamoto aims to establish a diversified Bitcoin operating company, leveraging its global distribution network and asset management capabilities to further drive Bitcoin's long-term growth and market expansion.
See More
NAKAMOTO INC: TOTAL VALUE OF THIS ASSESSMENT REACHES $107,295,354
- Combined Value: The total combined value of the consideration is $107,295,354.
See More
KindlyMD Rebrands to Nakamoto, Aligns with Bitcoin Strategy
- Corporate Rebranding: KindlyMD has rebranded to Nakamoto to align its corporate identity with its long-term strategy in the Bitcoin ecosystem, continuing healthcare operations through wholly-owned subsidiary Kindly LLC to ensure business continuity.
- Bitcoin Treasury Accumulation: The company has established a Bitcoin treasury worth over $500 million, enhancing its scalable operating and treasury platform through strategic investments and treasury asset allocations across multiple international markets.
- Share Repurchase Program: KindlyMD has authorized a share repurchase program, indicating confidence in its intrinsic value and potentially enhancing earnings per share by reducing the number of shares outstanding.
- Financial Performance: KindlyMD reported a GAAP EPS of -$0.42, missing expectations by $0.41, with revenue of $0.39 million slightly below projections, reflecting challenges during its transformation process.
See More
Nakamoto Inc. Rebrands to Align with Bitcoin Strategy, Holds Over $500 Million in Bitcoin Treasury
- Corporate Rebranding: Nakamoto Inc. has changed its name from KindlyMD, Inc. to Nakamoto Inc. to better align with its long-term strategy in the Bitcoin ecosystem, thereby eliminating ambiguity around the company's objectives.
- Bitcoin Treasury Accumulation: Since implementing its Bitcoin-focused strategy, Nakamoto has accumulated a Bitcoin treasury worth over $500 million and made strategic investments across multiple international markets, demonstrating its strong financial position in the Bitcoin sector.
- Subsidiary Operations: The healthcare business will continue operations through its wholly-owned subsidiary Kindly LLC, ensuring a clear division between healthcare and Bitcoin operations, which enhances overall operational efficiency.
- Future Development Plans: Nakamoto aims to build a global portfolio of Bitcoin-native companies through disciplined capital accumulation and acquisitions, intending to provide commercial and financial infrastructure for the next generation of capital markets.
See More
TG Therapeutics Reports $616 Million Revenue for FY 2025, Shares Surge 11.6%
- Strong Financial Performance: TG Therapeutics reported preliminary total global revenue of approximately $616 million for FY 2025, with Q4 U.S. net product revenue for BRIUMVI at about $182 million, indicating robust market performance that is expected to boost shareholder confidence.
- Significant Stock Surge: Following the earnings report, TG Therapeutics shares jumped 11.6% to $31.10 on Wednesday, reflecting investor optimism about the company's growth potential, which may attract more capital inflow.
- Positive Market Reaction: Despite a broader market decline with the Nasdaq Composite falling over 200 points, TG Therapeutics' strong financial data allowed it to stand out among numerous stocks, showcasing its competitiveness in the biopharmaceutical sector.
- Optimistic Future Outlook: Although the financial figures are unaudited, the preliminary results suggest that the company is poised for continued growth, particularly in the marketing of its BRIUMVI product, which could further enhance its market share.
See More
Nakamoto Completes Acquisition of BTC Inc and UTXO
- Transaction Completion: Nakamoto Inc. successfully completed the acquisition of BTC Inc and UTXO, with a total transaction value of $81.6 million paid in Nakamoto common stock, marking a significant consolidation and expansion in the Bitcoin sector.
- Financial Performance: According to preliminary unaudited results, BTC Inc and UTXO generated approximately $80.5 million in revenue, $34.2 million in EBITDA, and $40.1 million in net income for the 12-month period ending September 30, 2025, demonstrating strong profitability and market positioning.
- Market Leadership: BTC Inc, as the world's largest Bitcoin media company, operates 27 media brands reaching around 6 million people, with its Bitcoin Conference attracting 67,000 attendees, further solidifying its leadership in the Bitcoin ecosystem.
- Investment and Advisory Services: UTXO serves as an adviser to 210k Capital, focusing on Bitcoin-related investments, and is expected to leverage its extensive experience in the Bitcoin ecosystem to enhance Nakamoto's capital allocation across public and private markets, strengthening the company's investment portfolio.
See More
Nakamoto Acquires BTC Inc and UTXO to Expand Bitcoin Services
- Strategic Acquisition: Nakamoto Inc. announced the acquisition of BTC Inc, a leading Bitcoin media company, and UTXO, an investment firm focused on Bitcoin, with the transaction expected to close in Q1 2026, marking a significant step in the company's Bitcoin ecosystem strategy.
- Equity Financing: The transaction will be financed entirely with Nakamoto common stock at a price of $1.12 per share, with BTC Inc and UTXO securityholders receiving 363,589,816 shares, representing a total value of $107,295,354, reflecting the company's confidence in future growth.
- Market Leadership: BTC Inc is the largest Bitcoin media company globally, with a portfolio of 27 media brands reaching approximately 6 million people, and its leadership in Bitcoin events will provide Nakamoto with substantial market influence and brand value.
- Growth Potential: By integrating BTC Inc and UTXO, Nakamoto aims to establish a diversified Bitcoin operating company, leveraging its global distribution network and asset management capabilities to further drive Bitcoin's long-term growth and market expansion.
See More
NAKAMOTO INC: TOTAL VALUE OF THIS ASSESSMENT REACHES $107,295,354
- Combined Value: The total combined value of the consideration is $107,295,354.
See More
KindlyMD Rebrands to Nakamoto, Aligns with Bitcoin Strategy
- Corporate Rebranding: KindlyMD has rebranded to Nakamoto to align its corporate identity with its long-term strategy in the Bitcoin ecosystem, continuing healthcare operations through wholly-owned subsidiary Kindly LLC to ensure business continuity.
- Bitcoin Treasury Accumulation: The company has established a Bitcoin treasury worth over $500 million, enhancing its scalable operating and treasury platform through strategic investments and treasury asset allocations across multiple international markets.
- Share Repurchase Program: KindlyMD has authorized a share repurchase program, indicating confidence in its intrinsic value and potentially enhancing earnings per share by reducing the number of shares outstanding.
- Financial Performance: KindlyMD reported a GAAP EPS of -$0.42, missing expectations by $0.41, with revenue of $0.39 million slightly below projections, reflecting challenges during its transformation process.
See More
Nakamoto Inc. Rebrands to Align with Bitcoin Strategy, Holds Over $500 Million in Bitcoin Treasury
- Corporate Rebranding: Nakamoto Inc. has changed its name from KindlyMD, Inc. to Nakamoto Inc. to better align with its long-term strategy in the Bitcoin ecosystem, thereby eliminating ambiguity around the company's objectives.
- Bitcoin Treasury Accumulation: Since implementing its Bitcoin-focused strategy, Nakamoto has accumulated a Bitcoin treasury worth over $500 million and made strategic investments across multiple international markets, demonstrating its strong financial position in the Bitcoin sector.
- Subsidiary Operations: The healthcare business will continue operations through its wholly-owned subsidiary Kindly LLC, ensuring a clear division between healthcare and Bitcoin operations, which enhances overall operational efficiency.
- Future Development Plans: Nakamoto aims to build a global portfolio of Bitcoin-native companies through disciplined capital accumulation and acquisitions, intending to provide commercial and financial infrastructure for the next generation of capital markets.
See More
TG Therapeutics Reports $616 Million Revenue for FY 2025, Shares Surge 11.6%
- Strong Financial Performance: TG Therapeutics reported preliminary total global revenue of approximately $616 million for FY 2025, with Q4 U.S. net product revenue for BRIUMVI at about $182 million, indicating robust market performance that is expected to boost shareholder confidence.
- Significant Stock Surge: Following the earnings report, TG Therapeutics shares jumped 11.6% to $31.10 on Wednesday, reflecting investor optimism about the company's growth potential, which may attract more capital inflow.
- Positive Market Reaction: Despite a broader market decline with the Nasdaq Composite falling over 200 points, TG Therapeutics' strong financial data allowed it to stand out among numerous stocks, showcasing its competitiveness in the biopharmaceutical sector.
- Optimistic Future Outlook: Although the financial figures are unaudited, the preliminary results suggest that the company is poised for continued growth, particularly in the marketing of its BRIUMVI product, which could further enhance its market share.
See More
